Real life data on advanced cutaneous T cell lymphoma patients treated with brentuximab vedotin: results from a multicenter European EORTC study. (2019) - Papadavid, E.; Pappa, V.; Kapniari, E.; Nikolaou, V.; Hliakis, T.; Dalamaga, M.; Jonak, C.; Porkert, S.; Engelina, S.; Quaglino, P.; Ortiz Romero, P.; Cozzio, A.; et al.